166 related articles for article (PubMed ID: 37184033)
1. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
[TBL] [Abstract][Full Text] [Related]
2. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
3. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
[TBL] [Abstract][Full Text] [Related]
4. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
[TBL] [Abstract][Full Text] [Related]
6. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
[TBL] [Abstract][Full Text] [Related]
9. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
[TBL] [Abstract][Full Text] [Related]
10. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
11. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
12. Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic.
Maki KR; Steiger SN; Su Y; Boumiza A; Tan CA; Kerpelev M; Seo SK; Cohen N
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):413-419. PubMed ID: 35616016
[TBL] [Abstract][Full Text] [Related]
13. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
F1000Res; 2022; 11():30. PubMed ID: 35811795
[No Abstract] [Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
Wang L; Amin AK; Khanna P; Aali A; McGregor A; Bassett P; Gopal Rao G
J Antimicrob Chemother; 2021 Feb; 76(3):796-803. PubMed ID: 33185241
[TBL] [Abstract][Full Text] [Related]
16. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.
Gerver SM; Guy R; Wilson K; Thelwall S; Nsonwu O; Rooney G; Brown CS; Muller-Pebody B; Hope R; Hall V
Clin Microbiol Infect; 2021 Nov; 27(11):1658-1665. PubMed ID: 34481722
[TBL] [Abstract][Full Text] [Related]
17. Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections.
Duan Y; Wang J; Wang S; Zhang R; Hu J; Li W; Chen B
Eur J Clin Microbiol Infect Dis; 2024 Mar; 43(3):577-586. PubMed ID: 38246947
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
Sathyakamala R; Peace AR; Shanmugam P
J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
[TBL] [Abstract][Full Text] [Related]
19. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
[TBL] [Abstract][Full Text] [Related]
20. Bacterial co-infections with SARS-CoV-2.
Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
